Trial Profile
A phase II trial of TG 4010 + vinorelbine + cisplatin in patients with non-small cell lung cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs TG 4010 (Primary) ; Cisplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.